🇺🇸 FDA

Drug profile · INN

cefpodoxime proxetil

CEFPODOXIME PROXETIL

approved
US status
approved
Patents linked
3
News articles
0

Quick answer

cefpodoxime proxetil (CEFPODOXIME PROXETIL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN cefpodoxime proxetil
Brand CEFPODOXIME PROXETIL
Route ORAL
Formulation TABLET

Related patents

Search patents →

  1. US 10500271

    Compositions and methods for self-adjuvanting vaccines against microbes and tumors

    Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10265394

    Compositions and methods for self-adjuvanting vaccines against microbes and tumors

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10238734

    Compositions and methods for self-adjuvanting vaccines against microbes and tumors

    Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is cefpodoxime proxetil?

cefpodoxime proxetil (CEFPODOXIME PROXETIL) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for cefpodoxime proxetil?

CEFPODOXIME PROXETIL is a marketed brand name for cefpodoxime proxetil. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of cefpodoxime proxetil?

cefpodoxime proxetil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.